Prostate cancer: open trials in Taiwan

31 open trials have a site in Taiwan. Registry data; only the trial team decides who can take part.

NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
China Medical University Hospital-Department of Urology ( Site 1503), Taichung · National Cheng Kung University Hospital-Urology ( Site 1502), Tainan · Taipei Veterans General Hospital ( Site 1505), Taipei · National Taiwan University Hospital-Urology ( Site 1506), Taipei · Chang Gung Medical Foundation-Linkou Branch-Medical Oncology ( Site 1504), Taoyuan
Registry updated 2026-11-05
NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Chang Kung Memorial Hospital, Kaohsiung City · China Medical University Hospital, Taichung · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei
Registry updated 2026-11-04
NCT07164443
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Chang Gung Memorial Hospital, Kaohsiung City · Tungs' Taichung MetroHarbor Hospital, Taichung · Taichung Veterans General Hospital, Taichung · National Taiwan University Hospital, Taipei · Taipei Veterans General Hospital, Taipei · Linkou Chang Gung Memorial Hospital, Taoyuan
Registry updated 2026-11-03
NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
China Medical University Hospital, Taichung · Tungs' Taichung MetroHarbor Hospital, Taichung · Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · Linkou Chang Gung Memorial Hospital, Taoyuan
Registry updated 2026-11-03
NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Trial Treatment · Phase 3 · Pfizer
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · Taipei Veterans General Hospital, Taipei · National Taiwan University Hospital, Taipei
Registry updated 2026-10-30
NCT06925737
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Chang Gung Medical Foundation - Kaohsiung ( Site 0872), Kaohsiung City · Taichung Veterans General Hospital ( Site 0873), Taichung · Taipei Veterans General Hospital ( Site 0875), Taipei · National Taiwan University Hospital ( Site 0870), Taiwan
Registry updated 2026-10-30
NCT07288359
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Taipei
Registry updated 2026-10-29
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · Taipei Veterans General Hospital, Taipei · National Taiwan University Hospital, Taipei · Koo Foundation Sun Yat-Sen Cancer Center, Taipei · MacKay Memorial Hospital, Taipei · Chang Gung Memorial Hospital, Taoyuan
Registry updated 2026-10-26
NCT05914116
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Trial Treatment · Phase 1/2 · DualityBio Inc.
Kaohsiung City · Kaohsiung City · New Taipei City · Taipei · Taipei · Taipei · Taipei · Taipei · Taoyuan
Registry updated 2026-10-21
NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Taipei · Taoyuan
Registry updated 2026-10-21
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Kaohsiung Veterans General Hospital ( Site 1337), Kaohsiung City · Chang Gung Memorial Hospital at Kaohsiung-Oncology and Hematology ( Site 1331), Kaohsiung City · Taichung Veterans General Hospital ( Site 1338), Taichung · China Medical University Hospital-Department of Urology ( Site 1335), Taichung · Chi Mei Medical Center ( Site 1336), Tainan · Taipei Veterans General Hospital ( Site 1332), Taipei · Chang Gung Medical Foundation-Linkou Branch-Urology ( Site 1334), Taoyuan
Registry updated 2026-10-20
NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Trial Treatment · Phase 3 · Amgen
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei
Registry updated 2026-10-20
NCT07611110
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Trial Treatment · Phase 3 · AstraZeneca
Kaohsiung City · Taipei · Taoyuan
Registry updated 2026-10-19
NCT06855277
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Kaohsiung City · Taichung · Tainan · Taipei · Taoyuan
Registry updated 2026-10-15
NCT07711002
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Trial Treatment · Phase 3 · AstraZeneca
Kaohsiung City · Taichung · Tainan · Taipei · Taoyuan
Registry updated 2026-10-15
NCT06952803
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Trial Treatment · Phase 3 · AstraZeneca
Kaohsiung City · Taichung · Tainan · Taipei · Taoyuan
Registry updated 2026-10-14
NCT07028853
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Trial Treatment · Phase 3 · Pfizer
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei · Taipei Veterans General Hospital, Taipei
Registry updated 2026-10-14
NCT06863272
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Taichung Veterans General Hospital ( Site 0902), Taichung · Taipei Veterans General Hospital ( Site 0901), Taipei
Registry updated 2026-10-09
NCT05489211
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Trial Treatment · Phase 2 · AstraZeneca
Liou Ying Township · Taipei · Taoyuan
Registry updated 2026-09-23
NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Trial Treatment · Phase 2/3 · Novartis Pharmaceuticals
Taipei · Taoyuan
Registry updated 2026-09-22
NCT03237026
Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients
Research · National Taiwan University Hospital
National Taiwan University, Taipei
Registry updated 2026-09-21
NCT07005154
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Trial Treatment · Phase 2 · Astellas Pharma Global Development, Inc.
Kaohsiung City · Taichung · Taipei
Registry updated 2026-09-03
NCT04221542
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Trial Treatment · Phase 1 · Amgen
National Taiwan University Hospital, Taipei · Linkou Chang Gung Memorial Hospital of Chang Gung Medical Foundation, Taoyuan
Registry updated 2026-08-21
NCT07621692
Exploring Auger-Enhanced PSMA-Targeted Radioligand Therapy: A First-in-Taiwan Clinical Study of 161Tb-PSMA-I&T
Trial Treatment · Phase 1 · National Taiwan University Hospital
National Taiwan University Cancer Center, Taipei · National Taiwan University Hospital, Taipei
Registry updated 2026-06-02
NCT07196488
Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
Trial Treatment · National Taipei University of Nursing and Health Sciences
Keelung Chang Gung Memorial Hospital, Keelung · Linkou Chang Gung Memorial Hospital, Taoyuan
Registry updated 2026-05-19

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error